Tetanus: Clinical Trials

4 trials for Tetanus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 11Unknown 1

Follow Tetanus: new trials by email Literature Review of Tetanus trials Research Report on Tetanus

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus
Phase 2UnknownLG Chem3362024-10-022024-10-01
Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants
DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV - Diphtheria, Tetanus
Phase 2UnknownLG Chem3362019-11-012019-09-06
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
GC3111 vaccine, Boostrix® vaccine - Tetanus, Diphtheria
Phase 2UnknownGreen Cross Corporation2132019-10-142020-01-23
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Biological: GC3111 vaccine, Biological: Boostrix® vaccine - Tetanus, Diphtheria
Phase 1 / Phase 2UnknownGreen Cross Corporation2202016-06-012016-11-07

Narrower conditions

Diphtheria (4)  ·  Whooping Cough (4)  ·  Haemophilus Infections (2)  ·  Hepatitis B (2)  ·  Poliomyelitis (2)

Broader conditions

Actinomycetales Infections (4)  ·  Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Bordetella Infections (4)  ·  Clostridium Infections (4)  ·  Corynebacterium Infections (4)  ·  Gram-Negative Bacterial Infections (4)  ·  Gram-Positive Bacterial Infections (4)  ·  Infections (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Infections (4)  ·  Blood-Borne Infections (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Communicable Diseases (2)

Interventions

Boostrix (2)  ·  Vaccines, Combined (1)

Sponsors

Green Cross Corporation (2)  ·  LG Chem (2)

Countries

South Korea (2)